LOGIN
Botulinum toxin A with cast treatment for idiopathic toe-walking does not improve outcome
May 2013
Botulinum toxin A with cast treatment for idiopathic toe-walking does not improve outcome
Study Type:Therapy
OE Level Evidence:2
Journal Level of Evidence:N/A
Botulinum toxin a does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial
J Bone Joint Surg Am. 2013 Mar 6;95(5):400-7. doi: 10.2106/JBJS.L.00889Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
OE EXCLUSIVE
Dr.Engstrom discusses the use of Botulinum toxin A with cast treatment for idiopathic toe-walking
Synopsis
52 children were randomized to examine whether the addition of botulinum toxin A prior to cast treatment was effective in managing idiopathic toe-walking. Patients were treated with either 4 weeks of below-the-knee casts alone or 4 weeks of cast treatment 1 to 2 weeks following botulinum toxin A injections into the calves. The assessment at 12 months revealed that botulinum toxin A injections with...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.